EASTAMPTON, NJ, March 21, 2017 /PRNewswire/ – Epicore BioNetworks Inc. announces that it has granted stock options to non-executive directors, officers and to employees of the company.  The number of options granted is 600,000, which is equivalent to 1.1% of Epicore’s issued common stock. Of these options, 325,000 were issued to directors and officers.  Under the terms of the Epicore Stock Option Plan, options may be issued from time to time in any amount up to a maximum of 7,599,241 Epicore common shares. After issuance of these grants 2,945,913 options are outstanding.  These options have an exercise price of Cdn $0.89 and expire in five years.  The grant to directors follows Company board compensation policy. 

Epicore BioNetworks Inc. is a public corporation with a registered office in Calgary, Alberta, Canada and with shares listed on the Canadian Venture Exchange (symbol EBN).  [The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.]

SOURCE Epicore BioNetworks Inc.